首页> 外文OA文献 >Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

【2h】

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

机译：单次吸入三联疗法与吸入皮质类固醇联合长效β2-激动剂治疗慢性阻塞性肺疾病（TRILOGY）：双盲，平行组，随机对照试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Few data are available for the efficacy of "triple therapy" with two long-acting bronchodilators and an inhaled corticosteroid in chronic obstructive pulmonary disease (COPD). We designed this study to assess efficacy of single-inhaler combination of an extra fine formulation of beclometasone dipropionate, formoterol fumarate, and glycopyrronium bromide (BDP/FF/GB) in COPD compared with beclometasone dipropionate and formoterol fumarate (BDP/FF) treatment.

机译：在慢性阻塞性肺疾病（COPD）中，很少有关于使用两种长效支气管扩张药和吸入皮质类固醇的“三联疗法”疗效的数据。我们设计了这项研究，以评估比巴氯米松二丙酸酯和福莫特罗富马酸酯（BDP / FF）治疗的超精细制剂倍氯米松双丙酸酯，福莫特罗富马酸酯和格隆溴铵（BDP / FF / GB）的单吸入器组合在COPD中的疗效。

著录项

作者
Singh, Dave; Papi, Alberto; Corradi, Massimo; Pavlišová, Ilona; Montagna, Isabella; Francisco, Catherine; Cohuet, Géraldine; Vezzoli, Stefano; Scuri, Mario; Vestbo, Jørgen;
展开▼
作者单位

展开▼
年度 2016
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
中文文献
专利

1. Single inhaler triple therapy versus inhaled corticosteroid plus long-acting beta(2)-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial [J] . Singh Dave, Papi Alberto, Corradi Massimo, The Lancet . 2016,第10048期

机译：单吸入器三联疗法与吸入性糖皮质激素加长效β（2）激动剂治疗慢性阻塞性肺疾病（TRILOGY）：双盲，平行组，随机对照试验
2. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): a double-blind, parallel group, randomised controlled trial [J] . Vestbo Jorgen, Papi Alberto, Corradi Massimo, The Lancet . 2017,第10082期

机译：单一吸入器外列三倍治疗与长效毒蕈碱拮抗剂治疗慢性阻塞性肺病（三位一体）：双盲，平行组，随机对照试验
3. Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial (vol 391, pg 1076, 2018) [J] . Thiele E. A., Papi A., Marsh E. D., The Lancet . 2018,第10125期

机译：预吸入三重治疗与双支气管扩张剂治疗慢性阻塞性肺病（致敬）：双盲，平行组，随机对照试验（Vol 391，PG 1076,2018）
4. An Automated Therapy Chair for Patients having Chronic Obstructive Pulmonary Disease (COPD) [C] . Md. Faizul Islam Chowdhury, S. M. Lutful Kabir, Sheikh Md. Rashedul Hasan IEEE International Conference on Biomedical Engineering, Computer and Information Technology for Health . 2019

机译：慢性阻塞性肺疾病（COPD）患者的自动治疗椅
5. Economic evaluation of treating chronic obstructive pulmonary disease: The effects of early initiation of inhaled corticosteroids on exacerbation risks, utilization and costs. [D] . Akazawa, Manabu. 2007

机译：治疗慢性阻塞性肺疾病的经济评估：早期吸入皮质类固醇激素对恶化风险，利用和成本的影响。
6. Efficacy and safety of single-inhaler extrafine triple therapy versus inhaled corticosteroid plus long-acting beta2 agonist in eastern Asian patients with COPD: the TRIVERSYTI randomised controlled trial [O] . Jinping Zheng, Simonetta Baldi, Li Zhao, 2021

机译：单吸入器外列三重治疗的疗效和安全性与吸入皮质类固醇加上东亚患者的长效β2激动剂：Triversyti随机对照试验
7. Single inhaler extrafine triple therapy versus long-acting muscarinic antagonist therapy for chronic obstructive pulmonary disease (TRINITY): A double-blind, parallel group, randomised controlled trial [O] . Vestbo, Jørgen, Papi, Alberto, Corradi, Massimo, 2017

机译：单次吸入超细三联疗法与长效毒蕈碱拮抗剂治疗慢性阻塞性肺疾病（TRINITY）：双盲，平行组，随机对照试验

Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trial

摘要

著录项

相似文献

相关主题

期刊订阅